Alternative splicing in serotonergic system: Implications in neuropsychiatric disorders

Abi-Dargham A (2007) Alterations of serotonin transmission in schizophrenia. Int Rev Neurobiol 78: 133–164.

Abumaria N Ribic A Anacker C , et al. (2008) Stress upregulates TPH1 but not TPH2 mRNA in the rat dorsal raphe nucleus: Identification of two TPH2 mRNA splice variants. Cell Mol Neurobiol 28: 331–342.

Akil H Gordon J Hen R , et al. (2018) Treatment resistant depression: A multi-scale, systems biology approach. Neurosci Biobehav Rev 84: 272–288.

Amigo J Diaz A Pilar-Cuellar F , et al. (2016) The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor. Neuropharmacology 111: 47–58.

Arai R Kimura H Nagatsu I , et al. (1997) Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: A detailed enzyme histochemical study. Brain Res 745: 352–356.

Azim S Banday AR Tabish M (2012) Identification of alternatively spliced multiple transcripts of 5-hydroxytryptamine receptor in mouse. Brain Res Bull 87: 250–258.

Bach-Mizrachi H Underwood MD Tin A , et al. (2008) Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol Psychiatry 13: 507–513, 465.

Bender E Pindon A van Oers I , et al. (2000) Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant. J Neurochem 74: 478–489.

Bindereif A (2015) Pre-mRNA splicing: From protein-coding to noncoding RNAs. RNA 21: 571–572.

Biondo A (2017) Modulating Alternative Splicing of MAO-A Gene Transcript. Available at: http://www.biotechniques.org/students/2017/alyssa/paper.

Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Ann Rev Biochem 72: 291–336.

Blasi G De Virgilio C Papazacharias A , et al. (2013) Converging evidence for the association of functional genetic variation in the serotonin receptor 2a gene with prefrontal function and olanzapine treatment. JAMA Psychiatry 70: 921–930.

Bockaert J Claeysen S Compan V , et al. (2004) 5-HT4 receptors. Curr Drug Targets CNS Neurol Disord 3: 39–51.

Bonhaus DW Bach C DeSouza A , et al. (1995) The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: Comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol 115: 622–628.

Booij L Wang D Levesque ML , et al. (2013) Looking beyond the DNA sequence: The relevance of DNA methylation processes for the stress-diathesis model of depression. Philos Trans R Soc Lond B Biol Sci 368: 20120251.

Bratkovic T Modic M Camargo Ortega G , et al. (2018) Neuronal differentiation induces SNORD115 expression and is accompanied by post-transcriptional changes of serotonin receptor 2c mRNA. Sci Rep 8: 5101.

Brattelid T Kvingedal AM Krobert KA , et al. (2004) Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i). Naunyn Schmiedebergs Arch Pharmacol 369: 616–628.

Bruss M Barann M Hayer-Zillgen M , et al. (2000) Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms. Naunyn Schmiedebergs Arch Pharmacol 362: 392–401.

Cai Z (2014) Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer’s disease (Review). Mol Med Rep 9: 1533–1541.

Caspi A Sugden K Moffitt TE , et al. (2003) Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301: 386–389.

Castensson A Aberg K McCarthy S , et al. (2005) Serotonin receptor 2C (HTR2C) and schizophrenia: Examination of possible medication and genetic influences on expression levels. Am J Med Genet B Neuropsychiatr Genet 134B: 84–89.

Chagraoui A Thibaut F Skiba M , et al. (2016) 5-HT2C receptors in psychiatric disorders: A review. Prog Neuropsychopharmacol Biol Psychiatry 66: 120–135.

Chameau P van Hooft JA (2006) Serotonin 5-HT(3) receptors in the central nervous system. Cell Tissue Res 326: 573–581.

Charnay Y Leger L (2010) Brain serotonergic circuitries. Dialogues Clin Neurosci 12: 471–487.

Cheah SY Lawford BR Young RM , et al. (2017) mRNA expression and DNA methylation analysis of serotonin receptor 2A (HTR2A) in the human schizophrenic brain. Genes (Basel) 8.

Chen GL Miller GM (2013) Tryptophan hydroxylase-2: An emerging therapeutic target for stress disorders. Biochem Pharmacol 85: 1227–1233.

Chen NH Reith ME Quick MW (2004) Synaptic uptake and beyond: The sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch 447: 519–531.

Chen Y Xu H Zhu M , et al. (2017) Stress inhibits tryptophan hydroxylase expression in a rat model of depression. Oncotarget 8: 63247–63257.

Chou YH Hsieh WC Chen LC , et al. (2016) Association between the serotonin transporter and cytokines: Implications for the pathophysiology of bipolar disorder. J Affect Disord 191: 29–35.

Cooper A Woulfe D Kilic F (2019) Post-translational modifications of serotonin transporter. Pharmacol Res 140: 7–13.

Costall B Naylor RJ (2004) 5-HT3 receptors. Curr Drug Targets CNS Neurol Disord 3: 27–37.

Cowen P Sherwood AC (2013) The role of serotonin in cognitive function: Evidence from recent studies and implications for understanding depression. J Psychopharmacol 27: 575–583.

de Bruin NM Kruse CG (2015) 5-HT6 receptor antagonists: Potential efficacy for the treatment of cognitive impairment in schizophrenia. Curr Pharm Des 21: 3739–3759.

de Leeuw AS Westenberg HG (2008) Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo. J Psychiatr Res 42: 894–901.

De Lucchini S Marracci S Nardi I (2001) The serotonin 5-HT2B receptor from the puffer fish Tetraodon fluviatilis: cDNA cloning, genomic organization and alternatively spliced variants. Brain Res Mol Brain Res 97: 89–93.

De Ponti F Tonini M (2001) Irritable bowel syndrome: New agents targeting serotonin receptor subtypes. Drugs 61: 317–332.

Di Narzo AF Kozlenkov A Roussos P , et al. (2014) A unique gene expression signature associated with serotonin 2C receptor RNA editing in the prefrontal cortex and altered in suicide. Hum Mol Genet 23: 4801–4813.

Duxon MS Kennett GA Lightowler S , et al. (1997) Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. Neuropharmacology 36: 601–608.

Du Y Stasko M Costa AC , et al. (2007) Editing of the serotonin 2C receptor pre-mRNA: Effects of the Morris Water Maze. Gene 391: 186–197.

East SZ Burnet PW Leslie RA , et al. (2002) 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: Autoradiographic studies with [125I]SB-258585. Synapse 45: 191–199.

Egawa J Watanabe Y Endo T , et al. (2013) Association of rs2129575 in the tryptophan hydroxylase 2 gene with clinical phenotypes of autism spectrum disorders. Psychiatry Clin Neurosci 67: 457–458.

Endo T Minami M Hirafuji M , et al. (2000) Neurochemistry and neuropharmacology of emesis: the role of serotonin. Toxicology 153: 189–201.

Frau R Fanni S Serra V , et al. (2019) Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress. Neuropharmacology. Epub ahead of print 6 February 2019. DOI: 10.1016/j.neuropharm.2019.01.032.

Gao J Pan Z Jiao Z , et al. (2012) TPH2 gene polymorphisms and major depression: a meta-analysis. PLoS One 7: e36721.

Garcia-Garcia AL Newman-Tancredi A Leonardo ED (2014) 5-HT(1A) [corrected] receptors in mood and anxiety: Recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology (Berl) 231: 623–636.

Garfield AS Davies JR Burke LK , et al. (2016) Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads to disruption of 5HT2C receptor mediated appetite. Mol Brain 9: 95.

Gaweska H Fitzpatrick PF (2011) Structures and mechanism of the monoamine oxidase family. Biomol Concepts 2: 365–377.

Geissler JM Romanos M Gerlach M , et al. (2017) No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs. Atten Defic Hyperact Disord 9: 121–127.

Gelfman S Ast G (2013) When epigenetics meets alternative splicing: The roles of DNA methylation and GC architecture. Epigenomics 5: 351–353.

Gellynck E Laenen K Andressen KW , et al. (2008) Cloning, genomic organization and functionality of 5-HT(7) receptor splice variants from mouse brain. Gene 426: 23–31.

Ghasemi A Seifi M Baybordi F , et al. (2018) Association between serotonin 2A receptor genetic variations, stressful life events and suicide. Gene 658: 191–197.

Gill RK Pant N Saksena S , et al. (2008) Function, expression, and characterization of the serotonin transporter in the native human intestine. Am J Physiol Gastrointest Liver Physiol 294: G254–G262.

Gingrich JA Hen R (2001) Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 155: 1–10.

Glass JD Grossman GH Farnbauch L , et al. (2003) Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. J Neurosci 23: 7451–7460.

Grabowski P (2011) Alternative splicing takes shape during neuronal development. Curr Opin Genet Dev 21: 388–394.

Greenberg BD Li Q Lucas FR , et al. (2000) Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96: 202–216.

Grohmann M Hammer P Walther M , et al. (2010) Alternative splicing and extensive RNA editing of human TPH2 transcripts. PLoS One 5: e8956.

Grover M Camilleri M (2013) Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol 48: 177–181.

Guest PC Salim K Skynner HA , et al. (2000) Identification and characterization of a truncated variant of the 5-hydroxytryptamine(2A) receptor produced by alternative splicing. Brain Res 876: 238–244.

Gurevich I Englander MT Adlersberg M , et al. (2002) Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission. J Neurosci 22: 10529–10532.

Guthrie CR Murray AT Franklin AA , et al. (2005) Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. J Pharmacol Exp Ther 313: 1003–1010.

Hale MW Shekhar A Lowry CA (2011) Development by environment interactions controlling tryptophan hydroxylase expression. J Chem Neuroanat 41: 219–226.

Harries LW (2019) RNA biology provides new therapeutic targets for human disease. Front Genet 10: 205.

Havens MA Duelli DM Hastings ML (2013) Targeting RNA splicing for disease therapy. Wiley Interdiscip Rev RNA 4: 247–266.

Hedlund PB Kelly L Mazur C , et al. (2004) 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487: 125–132.

Heisler LK Zhou L Bajwa P , et al. (2007) Serotonin 5-HT(2C) receptors regulate anxiety-like behavior. Genes Brain Behav 6: 491–496.

Hubbard PC Thompson AJ Lummis SC (2000) Functional differences between splice variants of the murine 5-HT(3A) receptor: Possible role for phosphorylation. Brain Res Mol Brain Res 81: 101–108.

Issler O Haramati S Paul ED , et al. (2014) MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron 83: 344–360.

Jakubauskiene E Janaviciute V Peciuliene I , et al. (2012) G/A polymorphism in intronic sequence affects the processing of MAO-B gene in patients with Parkinson disease. FEBS Lett 586: 3698–3704.

Jean A Conductier G Manrique C , et al. (2007) Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens. Proc Natl Acad Sci USA 104: 16335–16340.

Karg K Burmeister M Shedden K , et al. (2011) The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation. Arch Gen Psychiatry 68: 444–454.

Kelemen O Convertini P Zhang Z , et al. (2013) Function of alternative splicing. Gene 514: 1–30.

Khanzada NS Butler MG Manzardo AM (2017) GeneAnalytics pathway analysis and genetic overlap among autism spectrum disorder, bipolar disorder and schizophrenia. Int J Mol Sci 18(3): E527.

Kim SH Seo M Hwang H , et al. (2019) Physical and functional interaction between 5-HT6 receptor and Nova–1. Exp Neurobiol 28: 17–29.

Kim SJ Veenstra-VanderWeele J Hanna GL , et al. (2000) Mutation screening of human 5-HT(2B)receptor gene in early-onset obsessive-compulsive disorder. Mol Cell Probes 14: 47–52.

Kloiber S Kohli MA Brueckl T , et al. (2010) Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Mol Psychiatry 15: 736–747.

Krobert KA Bach T Syversveen T , et al. (2001) The cloned human 5-HT7 receptor splice variants: A comparative characterization of their pharmacology, function and distribution. Naunyn Schmiedebergs Arch Pharmacol 363: 620–632.

Krobert KA Levy FO (2002) The human 5-HT7 serotonin receptor splice variants: Constitutive activity and inverse agonist effects. Br J Pharmacol 135: 1563–1571.

Le Francois B Zhang L Mahajan GJ , et al. (2018) A novel alternative splicing mechanism that enhances human 5-HT1A receptor RNA stability is altered in major depression. J Neurosci 38: 8200–8210.

Lev Maor G Yearim A Ast G (2015) The alternative role of DNA methylation in splicing regulation. Trends Genet 31: 274–280.

Lipscombe D Lopez Soto EJ (2019) Alternative splicing of neuronal genes: New mechanisms and new therapies. Curr Opin Neurobiol 57: 26–31.

Lira A Zhou M Castanon N , et al. (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54: 960–971.

Liu MT Kuan YH Wang J , et al. (2009) 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 29: 9683–9699.

Lucas G Rymar VV Du J , et al. (2007) Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55: 712–725.

Maillet M Robert SJ Lezoualc’h F (2004) New insights into serotonin 5-HT4 receptors: A novel therapeutic target for Alzheimer’s disease? Curr Alzheimer Res 1: 79–85.

Mallajosyula JK Kaur D Chinta SJ , et al. (2008) MAO-B elevation in mouse brain astrocytes results in Parkinson’s pathology. PLoS One 3: e1616.

Manfra O Van Craenenbroeck K Skieterska K , et al. (2015) Downregulation of 5-HT7 serotonin receptors by the atypical antipsychotics clozapine and olanzapine. Role of motifs in the C-terminal domain and interaction with GASP–1. ACS Chem Neurosci 6: 1206–1218.

Maron E Kuikka JT Ulst K , et al. (2004) SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci 254: 392–396.

Martin CB Hamon M Lanfumey L , et al. (2014) Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs. Neurosci Biobehav Rev 42: 208–223.

Martin CB Ramond F Farrington DT , et al. (2013) RNA splicing and editing modulation of 5-HT(2C) receptor function: Relevance to anxiety and aggression in VGV mice. Mol Psychiatry 18: 656–665.

McGlincy NJ Smith CW (2008) Alternative splicing resulting in nonsense-mediated mRNA decay: What is the meaning of nonsense? Trends Biochem Sci 33: 385–393.

Mendez-David I David DJ Darcet F , et al. (2014) Rapid anxiolytic effects of a 5-HT(4) receptor agonist are mediated by a neurogenesis-independent mechanism. Neuropsychopharmacology 39: 1366–1378.

Meneses A (2014) 5-HT7 receptor stimulation and blockade: A therapeutic paradox about memory formation and amnesia. Front Behav Neurosci 8: 207.

Menon V Kattimani S (2015) Suicide and serotonin: Making sense of evidence. Indian J Psychol Med 37: 377–378.

Molderings GJ (2012) Physiological, pathophysiological and therapeutic impact of the enteric serotonergic system. Arzneimittelforschung 62: 157–166.

Monti JM (2011) Serotonin control of sleep-wake behavior. Sleep Med Rev 15: 269–281.

Morozova M Burminskiy D Rupchev G , et al. (2017) 5-HT6 receptor antagonist as an adjunct treatment targeting residual symptoms in patients with schizophrenia: Unexpected sex-related effects (double-blind placebo-controlled trial). J Clin Psychopharmacol 37: 169–175.

Murray KC Nakae A Stephens MJ , et al. (2010) Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat Med 16: 694–700.

Nebigil CG Choi DS Dierich A , et al. (2000) Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97: 9508–9513.

Nichols DE Nichols CD (2008) Serotonin receptors. Chem Rev 108: 1614–1641.

Olsen MA Nawoschik SP Schurman BR , et al. (1999) Identification of a human 5-HT6 receptor variant produced by alternative splicing. Brain Res Mol Brain Res 64: 255–263.

Ottenhof KW Sild M Levesque ML , et al. (2018) TPH2 polymorphisms across the spectrum of psychiatric morbidity: A systematic review and meta-analysis. Neurosci Biobehav Rev 92: 29–42.

Ozsarac N Santha E Hoffman BJ (2002) Alternative non-coding exons support serotonin transporter mRNA expression in the brain and gut. J Neurochem 82: 336–344.

Palma-Gudiel H Fananas L (2017) An integrative review of methylation at the serotonin transporter gene and its dialogue with environmental risk factors, psychopathology and 5-HTTLPR. Neurosci Biobehav Rev 72: 190–209.

Pan YF Zhang JY Qiu HM , et al. (2019) Association of polymorphisms in HTR2A, TPH1, and TPH2 genes with attempted suicide in rural China. Psychiatr Genet 29: 79–85.

Peitl V Stefanovic M Karlovic D (2017) Depressive symptoms in schizophrenia and dopamine and serotonin gene polymorphisms. Prog Neuropsychopharmacol Biol Psychiatry 77: 209–215.

Pindon A van Hecke G van Gompel P , et al. (2002) Differences in signal transduction of two 5-HT4 receptor splice variants: Compound specificity and dual coupling with Galphas- and Galphai/o-proteins. Mol Pharmacol 61: 85–96.

Pompili M Gentile G Scassellati C , et al. (2017) Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients. Neurosci Lett 656: 94–102.

Porazinski S Ladomery M (2018) Alternative splicing in the hippo pathway: implications for disease and potential therapeutic targets. Genes (Basel) 9(3): E161.

Pratelli M Pasqualetti M (2018) Serotonergic neurotransmission manipulation for the understanding of brain development and function: Learning from Tph2 genetic models. Biochimie 161: 3–14.

Puig MV Gulledge AT (2011) Serotonin and prefrontal cortex function: Neurons, networks, and circuits. Mol Neurobiol 44: 449–464.

Ramirez MJ (2013) 5-HT6 receptors and Alzheimer’s disease. Alzheimers Res Ther 5: 15.

Rebholz H Friedman E Castello J (2018) Alterations of expression of the serotonin 5-HT4 receptor in brain disorders. Int J Mol Sci 19(11): 3581.

Rivera M Gutierrez B Molina E , et al. (2009) High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample. Am J Med Genet B Neuropsychiatr Genet 150B: 395–402.

Rocha-Gonzalez HI Meneses A Carlton SM , et al. (2005) Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test. Pain 117: 182–192.

Ruble CL Smith RM Calley J , et al. (2016) Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: Identification of novel HTR2A and antisense (HTR2A-AS1) exons. BMC Genet 17: 16.

Sarkisyan G Roberts AJ Hedlund PB (2010) The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior. Behav Brain Res 209: 99–108.

Schellekens H Clarke G Jeffery IB , et al. (2012) Dynamic 5-HT2C receptor editing in a mouse model of obesity. PLoS One 7: e32266.

Segelcke D Messlinger K (2017) Putative role of 5-HT2B receptors in migraine pathophysiology. Cephalalgia 37: 365–371.

Stamm S Gruber SB Rabchevsky AG , et al. (2017) The activity of the serotonin receptor 2C is regulated by alternative splicing. Hum Genet 136: 1079–1091.

Su CH, DD Tarn WY (2018) Alternative splicing in neurogenesis and brain development. Front Mol Biosci 5: 12.

Sun Y Zhang J Yuan Y , et al. (2012) Study of a possible role of the monoamine oxidase A (MAOA) gene in paranoid schizophrenia among a Chinese population. Am J Med Genet B Neuropsychiatr Genet 159B: 104–111.

Takehashi M Tanaka S Masliah E , et al. (2002) Association of monoamine oxidase A gene polymorphism with Alzheimer’s disease and Lewy body variant. Neurosci Lett 327: 79–82.

Tanaka M Sato A Kasai S , et al. (2018) Brain hyperserotonemia causes autism-relevant social deficits in mice. Mol Autism 9: 60.

Tauscher J Pirker W Willeit M , et al. (2001) [123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49: 326–332.

Thomas SJ Shin M McInnis MG , et al. (2015) Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: Strategies for the management of treatment-resistant depression. Pharmacotherapy 35: 433–449.

Turecki G Ernst C Jollant F , et al. (2012) The neurodevelopmental origins of suicidal behavior. Trends Neurosci 35: 14–23.

Twitchell GR Hanna GL Cook EH , et al. (2001) Serotonin transporter promoter polymorphism genotype is associated with behavioral disinhibition and negative affect in children of alcoholics. Alcohol Clin Exp Res 25: 953–959.

Tzvetkov MV Meineke C Oetjen E , et al. (2007) Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine. Gene 386: 52–62.

Vaswani M Linda FK Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27: 85–102.

Vijayendran M Cutrona C Beach SR , et al. (2012) The relationship of the serotonin transporter (SLC6A4) extra long variant to gene expression in an African American sample. Am J Med Genet B Neuropsychiatr Genet 159B: 611–612.

Wahl MC Will CL Luhrmann R (2009) The spliceosome: Design principles of a dynamic RNP machine. Cell 136: 701–718.

Waider J Araragi N Gutknecht L , et al. (2011) Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: A perspective. Psychoneuroendocrinology 36: 393–405.

Wang ET Ward AJ Cherone JM , et al. (2015) Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res 25: 858–871.

Weisstaub NV Zhou M Lira A , et al. (2006) Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313: 536–540.

Xiang C Liu S Fan Y , et al. (2019) Single nucleotide polymorphisms, variable number tandem repeats and allele influence on serotonergic enzyme modulators for aggressive and suicidal behaviors: A review. Pharmacol Biochem Behav 180: 74–82.

Zhang G Stackman RW Jr (2015) The role of serotonin 5-HT2A receptors in memory and cognition. Front Pharmacol 6: 225.

Zhang X Nicholls PJ Laje G , et al. (2011) A functional alternative splicing mutation in human tryptophan hydroxylase–2. Mol Psychiatry 16: 1169–1176.

Zhang Z Shen M Gresch PJ , et al. (2016) Oligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intake. EMBO Mol Med 8: 878–894.

Zhu LY Zhu YR Dai DJ , et al. (2018) Epigenetic regulation of alternative splicing. Am J Cancer Res 8: 2346–2358.